Document:EU Regulation (EC) No 726/2004 - authorisation and supervision of medicinal products for human use 28-Jan-22: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Gxplex admin (talk | contribs) m 1 revision imported |
(No difference)
| |
Revision as of 20:43, 27 June 2026
| Document information | |
|---|---|
| Reference | EU Regulation (EC) No 726/2004 -
authorisation and supervision of medicinal products for human use 28-Jan-22 |
| Validity area | EU |
| Scope(s) | NIS |
| Document name | Regulation (EC) No 726/2004 -
authorisation and supervision of medicinal products for human use |
| Version / Revision | 28-Jan-22 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance) |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:EU Regulation (EC) No 726/2004 - authorisation and supervision of medicinal products for human use 28-Jan-22 Article 26 | NIS | Article 26 | EN | Article 26 1. The Agency shall, in collaboration with the Member States and the Commission, set up and maintain a European medicines web-portal [EU PAS Register] for the dissemination of information ... |
